Sign In
Buy HUM
$327.54
+6.66 (+2.08%)
At Close: Jun 03, 2026
Humana Inc. (HUM) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript
11:13am, Wednesday, 19'th Nov 2025
Humana Inc. ( HUM ) 7th Annual Wolfe Research Healthcare Conference November 19, 2025 8:40 AM EST Company Participants Celeste Mellet - Chief Financial Officer Conference Call Participants Justin Lake
New Research from the Humana Foundation Examines Food Insecurity Crisis Among Kentucky Seniors
10:00am, Wednesday, 19'th Nov 2025
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. for the past 44 years, today announced the publication of its new issue brief, Senior Food Insecurity in K
CenterWell Home Health Branches Collect 287,000 Meals for Needy
09:00am, Tuesday, 18'th Nov 2025
LOUISVILLE, Ky.--(BUSINESS WIRE)--CenterWell Home Health branches collect 287,000 meals for needy.
Less Paperwork, More Connected Care: Humana and Epic Advance Data Sharing
07:50am, Tuesday, 18'th Nov 2025
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana and Epic advance data sharing through digital innovations that align with federal interoperability priorities and improve patient experience.
Berman Tabacco Announces Investigation of Humana, Inc. (NYSE:HUM)
11:09am, Monday, 17'th Nov 2025
BOSTON, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Berman Tabacco, a national law firm representing investors, announces its investigation into potential stockholder claims involving Humana, Inc (“Humana”)
Humana Inc. $HUM Shares Bought by Allworth Financial LP
03:43am, Monday, 17'th Nov 2025
Allworth Financial LP lifted its position in shares of Humana Inc. (NYSE: HUM) by 187.6% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 1,599 shares of the
Insurers Slide As Congress Postpones Decision On Health Subsidies, Delays Obamacare Subsidy Vote To December
12:58pm, Monday, 10'th Nov 2025
Shares of major health insurers slid Monday as investors reacted to a Senate deal that ended the 40-day U.S. government shutdown but failed to extend subsidies under the Affordable Care Act (ACA).
Humana Foundation Pledges $500,000 to Meet Surge in Demand for Food
08:00am, Monday, 10'th Nov 2025
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 44 years, today announced $500,000 in new investments to support food banks and n
Humana Inc. to Present at 2025 Wolfe Research Healthcare Conference
04:15pm, Thursday, 06'th Nov 2025
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Celeste Mellet, Chief Financial Officer, will make a presentation to investors at the Wolfe Research Healthcare Conferenc
Should Value Investors Buy Humana (HUM) Stock?
10:40am, Thursday, 06'th Nov 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Humana Inc (HUM) Q3 2025 Earnings Call Highlights: Strategic Investments and Operational Improvements Drive Future Growth
06:02pm, Wednesday, 05'th Nov 2025
EPS Outlook: Full year 2025 EPS outlook of approximately $17.Individual MA Pre-Tax Margin: Commitment to achieving at least 3% over time.Incremental Investment
Humana Beats Q3 Earnings on Premium Growth, Updates 2025 View
02:46pm, Wednesday, 05'th Nov 2025
HUM tops Q3 earnings forecasts on strong premium growth, even as higher costs and lower memberships weigh on results.
Humana's EPS Beat Overshadowed by Lowered GAAP Guidance and Medicare Concerns
12:14pm, Wednesday, 05'th Nov 2025
Humana (HUM) surpassed EPS expectations for the third quarter of 2025 and reaffirmed its full-year adjusted EPS guidance of around $17.00. Despite this, the sto
Humana Inc. (HUM) Q3 2025 Earnings Call Transcript
11:51am, Wednesday, 05'th Nov 2025
Humana Inc. ( HUM ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Lisa Stoner - Vice President of Investor Relations James Rechtin - President, CEO & Director Celeste Mellet
Humana's Q3 Beat Overshadowed By Weak 2025 EPS Guide And Rising Medical Costs
11:21am, Wednesday, 05'th Nov 2025
Humana receives a "Hold" rating due to fair valuation and ongoing underperformance versus the S&P 500. HUM's Q3 earnings beat expectations, but a light FY 2025 outlook and higher medical loss ratio pr
